Hutch News

Recent Stories

Good News at Fred Hutch

Celebrating faculty and staff achievements

Feb. 16, 2017

Dr. Keith Jerome

Dr. Keith Jerome

Photo by Robert Hood / Fred Hutch News Service

Dr. Keith Jerome, collaborators awarded amfAR grant for HIV cure research

A Fred Hutch and University of Washington team of virologists and bioengineers led by Dr. Keith Jerome has received a $200,000 grant — the first phase of up to $1.5 million in milestone-driven funding over four years — to develop nanocarrier technology to deliver therapies to reservoirs of dormant, HIV-infected cells.

The grant is from the New York-based amfAR, or Foundation for AIDS Research, as part of its “Countdown to a Cure for AIDS” initiative, which aims to achieve the scientific underpinnings of a cure by 2020. The hard-to-reach reservoirs are a key barrier to curing HIV.

Almost immediately upon infection, HIV begins to integrate itself into the DNA of some of the longest-lived cells of the body. There the virus lies dormant, unaffected by the lifesaving antiretroviral drugs that keep actively replicating HIV in check. But stop the medication, and the reservoirs rekindle infection. 

Continue reading >

Love in the time of cancer

Getting dumped after diagnosis isn’t the only story out there; meet three couples who found romance despite disease

Feb. 14, 2017 | By Diane Mapes / Fred Hutch News Service

Happy couple Susan and Jeff

Susan, a stage 4 breast cancer patient, and her brand new husband Jeff, shortly after their wedding in July 2016. The pair met via an online dating site while Susan was going through treatment. "When I told him I was hesitant to tell him about the cancer because I wasn’t sure if he would want to see me anymore, his answer was, ‘Can I see you again?’”

Photo courtesy of Jeff Salmore Photography

Six years ago, I spent Valentine’s weekend lurching around Seattle trying to come to terms with the fact that I was now a cancer patient. I was sort of dating someone at the time, but we weren’t tight enough to be a true couple so there were no roses, no romantic dinner, not even a lousy chocolate kiss.

Instead, I got the cancer kiss-off a few days later, although in capping our fledgling relationship, the guy swore up and down “It’s not the cancer, it’s you.”

Uh … thanks?

If you’ve lived in Cancerland for any length of time, you’ve probably heard stories of patients getting kicked to the curb after a diagnosis. Maybe you’ve even lived through it yourself. It’s a common enough occurrence that it’s been studied, most recently by Fred Hutchinson Cancer Research Center clinical researcher and Seattle Cancer Care Alliance neuro-oncologist Dr. Marc Chamberlain.

Continue reading >

Cake, candles and a wish for more HIV cures

An HIV workshop pays tribute to Timothy Ray Brown, whose cure 10 years ago fueled research — and hope

Feb. 13, 2017 | By Mary Engel / Fred Hutch News Service

Timothy Ray Brown

Timothy Ray Brown celebrates his 10th "birthday," marking the anniversary of the stem cell transplant that made him the first and so far only person in the world to be cured of the virus that causes AIDS.

Robert Hood / Fred Hutch News Service

“It happened, and it was a hard survival. But I’m here.”

With these words, Timothy Ray Brown blew out 10 candles on a chocolate birthday cake as a room full of researchers, activists and people living with HIV cheered.

A decade has passed since the first of two stem cell transplants cured Brown of both leukemia and HIV, making him the first and so far only person to be cured of the virus that causes AIDS. Sunday’s “birthday” celebration, a tradition among transplant cancer survivors, capped a day-long workshop on HIV cure research on the eve of a major HIV scientific meeting, the annual Conference on Retroviruses and Opportunistic Infections, or CROI, being held in Seattle.

The Seattle-born Brown flew in for the workshop and celebration from Palm Springs, California, where he now lives. Later this week, he’ll mark his original birthday, albeit a little early, with his mother. He turns 51 in March.

Dr. Gero Hütter, the German doctor who cured Brown, could not attend Sunday’s party in Seattle but sent a videotaped greeting. At the time of Brown’s transplant, scientists had considered a cure for HIV so unlikely that it took Hütter a year after first reporting the case to get a paper published in a medical journal.

“I think that you all agree with me that Timothy’s case, as a proof of principle, has changed a lot of the field of HIV research,” Hütter said in the video. “Timothy is the motivation for hundreds of researchers, fundraisers and activists to go forward to the big target that HIV/AIDS can be cured.”

But if Brown’s cure inspired the field of HIV cure research, he is also a reminder of the challenges that remain. 

Continue reading >

Good News at Fred Hutch

Celebrating faculty and staff achievements

Feb. 9, 2017

MarCom statuettes

The Fred Hutch Communications & Marketing team has received MarCom awards in seven different categories for all 12 projects submitted for consideration, including three honorable mentions, five gold awards and four platinum awards.

Photo by Bo Jungmayer / Fred Hutch News Service

Hutch Communications & Marketing wins 12 awards for creativity in 7 categories

Several teams from Fred Hutchinson Cancer Research Center's Communications & Marketing Department were recognized for their recent work with 12 2016 MarCom Awards, which recognize outstanding work by creative professionals in the marketing and communications fields.

The awards are administered by the Association of Marketing and Communications Professionals and are one of the most longstanding and largest creative competitions in the world. The 2016 competition received more than 6,000 entries. The Hutch team received awards in seven different categories for all 12 projects they submitted for consideration, including three honorable mentions, five gold awards and four platinum awards.

“Just as our world-class researchers have a great passion for their work, we too are passionate in driving a wider and deeper understanding of Fred Hutch,” said Kathryn Sweyer, Fred Hutch’s director of marketing. “To be recognized for doing what we love and to be doing it in service of the Hutch is incredibly rewarding.”

Continue reading >

Happy 10th 'birthday,' Timothy Ray Brown

A decade after the first and so far only known HIV cure, researchers are hard at work to find a cure for many more

Feb. 7, 2017 | By Mary Engel / Fred Hutch News Service

Gero Hütter, Timothy Ray Brown, Keith Jerome and Hans-Peter Kiem

Timothy Ray Brown (second from left) with Dr. Gero Hütter (far left), the German hematologist who did the transplant that cured him; and Fred Hutch researchers Drs. Keith Jerome and Hans-Peter Kiem during a visit to the Hutch campus in 2015.

Photo by Robert Hood / Fred Hutch News Service

It’s a tradition to celebrate the anniversary of a lifesaving bone marrow transplant as a rebirth. By that measure, today marks the 10th “birthday” of one of the world’s best known transplant survivors: Timothy Ray Brown.

On Feb. 7, 2007, Brown underwent a last-ditch effort to cure his life-threatening acute myeloid leukemia after chemotherapy failed. But what sets him apart from the million-plus transplant survivors worldwide who have been reborn free of leukemia and other blood cancers is that he became the first person in the world to also be cured of HIV.

A decade later, scientists at Fred Hutchinson Cancer Research Center and other institutions are working hard to make sure he will not remain the only person cured. Their challenge is to show that what once was thought impossible can be repeated and also to find a cure that is less risky and toxic than the one Brown endured. Finding a cure now commands a place on the agenda of every major scientific meeting on HIV, including next week’s Conference on Retroviral and Opportunistic Infections in Seattle.

“Cure is challenging because of the very special nature of HIV: how it attacks the body, how it integrates into our cells, and how the immune response, unlike for virtually any other virus, is inadequate,” said Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, at a recent international AIDS conference.

But, Fauci added, “We now have a cohort of dedicated scientists who are working in this field.”

The NIH helped foster this cohort. In 2011, it funded three public-private research groups, including the Fred Hutch-based defeatHIV, to focus on curing HIV. Last summer it awarded an additional $150 million over five years to be divided among the original partnerships as well as three new groups. All are led by U.S. researchers and based at U.S. institutions but each draws from academia and industry across the nation and abroad. This is an overview of the work they are undertaking.

Continue reading >

Proteowhatnow? 6 questions with a proteomics expert

How a new technology could help identify the best cancer treatment for an individual patient

Feb. 6, 2017 | by Susan Keown / Fred Hutch News Service

Mandy Paulovich

Dr. Amanda (Mandy) Paulovich

Photo by Bo Jungmayer / Fred Hutch

Proteomics expert Dr. Amanda Paulovich of Fred Hutchinson Cancer Research Center has just been tapped by federal agencies to create a panel of tests to measure key proteins that can serve as markers for tumors. Part of former Vice President Joe Biden’s Cancer Moonshot initiative, the effort could ultimately lead to treatments that are more specifically targeted to a patient’s distinct type of cancer.

We asked Paulovich six questions about proteomics: Why we should care, what she’s working on, and what she’s excited about.

Continue reading >


Support our quest for cures

Story Archive


Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.